Role of Sclerotherapy in Treatment of Non-neoplastic Ovarian Cyst

Inclusion Criteria: * Patients were diagnosed with non-neoplastic ovarian cysts (i.e., simple, hemorrhagic, complicated, endometriotic cysts). * All Patients from 15 to 48 years old. * Size from (5 to 10 cm). * Cyst wall thickness \< 5 mm. * Negative tumor markers (Cancr Antigen125, Cancer Embryonic Antigen, Cancer Antigen19.9 \& alpha fetoprotein). * Persisted for more than 3 months. * Normal color Doppler blood flow analysis. * Resistant to hormonal treatment COCs. * Patients accepted to be enrolled in the study. Exclusion Criteria: * Family history of ovarian cancer. * USG features suggesting malignancy like: multilocular, papillary projections or mural nodule, cyst wall thickness \>5mm, low Doppler indices (PI≤1 and or RI≤0.40, centrally located vessels, randomly dispersed vessels). * Known allergy to sclerosing agent (tetracycline or Polidocanol). * Bleeding tendency as (patients with platelet count \<50,000, patients with Uncorrected Coagulopathy with International Normalized Ratio \>1.5, or patients on antithrombotic therapy without stoppage of doses till 5 days before the procedure.